Griffith University’s Institute for Glycomics has been awarded a Medical Research grant of $100,000 from The Ian Potter Foundation to support their project ‘Pioneering Tissue Microdissection Glycomics for Better Patient Outcomes’.
This grant will enable the acquisition of a Laser Capture Microdissection system (LCM). This new piece of equipment will be integrated into the Institute’s suite of advanced analytical and imaging technologies.
The Institute is a pioneer of Tissue Imaging Microdissection Glycomics, which enables analysis of individual cells from within complex patient-derived tissue samples.
This unique approach is providing new insights into the precise molecular changes in cancers and infectious diseases; and is a critical component of the work underway within the Institute’s Australian Centre for Cancer Glycomics (A2CG) and the Fraunhofer International Consortium for Anti-Infective Research (iCAIR®).
“We are very grateful to The Ian Potter Foundation for this grant. The acquisition of the LCM system will have an immediate impact on our active programs focused on a range of cancers, including breast, ovarian, head and neck, and prostate; and intractable infectious diseases including highly pathogenic influenza, parainfluenza, antimicrobial-resistant infections and emerging pathogens of global impact,” said Professor Mark von Itzstein AO, Founder and Director of the Institute for Glycomics.
“It will also be a catalyst for further collaboration with researchers, clinicians and industry from across the globe to add to our already extensive networks to create new patient management tools; and drug, vaccine and diagnostics development.”
